MANILA - A new testing kit to check for coronavirus disease 2019 (Covid-19) infection is expected to be developed by May, according to the Department of Science and Technology (DOST). DOST Secretary Fortunato de la Pena said the new kit will be a cell-based immunoassay for serologic testing. "There are three types of tests available. The polymerase chain reaction testing and antigen testing can both test for active infection. Serological testing tests the antibodies against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and can detect whether a person was previously infected with Covid-19," he told the Philippine News Agency (PNA) on Monday night. The project is being supported by the DOST-Philippine Council for Health Research and Development (PCHRD) with funding worth close to PHP5 million. The DOST-PCHRD-funded project, "Development of a Cell-Based Immunoassay for Coronavirus Disease 2019 (Covid-19) Serologic Testing", is led by Dr. Fresthel Monica
MANILA - A new testing kit to check for coronavirus disease 2019 (Covid-19) infection is expected to be developed by May, according to the Department of Science and Technology (DOST). DOST Secretary Fortunato de la Pena said the new kit will be a cell-based immunoassay for serologic testing. "There are three types of tests available. The polymerase chain reaction testing and antigen testing can both test for active infection. Serological testing tests the antibodies against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and can detect whether a person was previously infected with Covid-19," he told the Philippine News Agency (PNA) on Monday night. The project is being supported by the DOST-Philippine Council for Health Research and Development (PCHRD) with funding worth close to PHP5 million. The DOST-PCHRD-funded project, "Development of a Cell-Based Immunoassay for Coronavirus Disease 2019 (Covid-19) Serologic Testing", is led by Dr. Fresthel Monica
The University of the Philippines (UP) Manila is currently developing a novel cell-based immunoassay platform for serologic testing for coronavirus disease (COVID-19).